Trials / Completed
CompletedNCT00140712
Ropinirole Tablets In Young Patients With Restless Legs Syndrome
A Study to Determine the Tolerability and Pharmacokinetics for Ropinirole in Paediatric / Adolescent Patients With RLS (Type 2)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 12 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
This is a two-period dose rising study of Ropinirole Immediate Release in adolescent patients with restless legs syndrome (RLS) in order to determine the starting dose for the ropinirole titration regimen for this age group. Patients will receive two single doses unless poor tolerability is observed following the first dose.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ropinirole Immediate Release | Ropinirole Immediate Release |
Timeline
- Start date
- 2005-06-10
- Primary completion
- 2008-02-28
- Completion
- 2008-02-28
- First posted
- 2005-09-01
- Last updated
- 2017-09-11
Locations
9 sites across 3 countries: United States, Belgium, France
Source: ClinicalTrials.gov record NCT00140712. Inclusion in this directory is not an endorsement.